Xenetic Biosciences (XBIO) EPS (Basic) (2011 - 2026)
Xenetic Biosciences' (XBIO) quarterly EPS (Basic) came in at -$17.61 in Q1 2026, up 35.79% YoY from -$12.97 in Q1 2025, and down 4710.82% on a QoQ basis from -$0.37 in Q4 2025.
Xenetic Biosciences (XBIO) EPS (Basic) (2011 - 2026) Analysis & Trends
Xenetic Biosciences (XBIO) has 16 years of EPS (Basic) data on file, last reported at -$17.61 in Q1 2026.
- Quarterly EPS (Basic) rose 35.79% year-over-year to -$17.61 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54.8 (up 33.06% YoY) and the FY2025 annual result came in at -$25.06, up 14.81% from the prior year.
- EPS (Basic) eased to -$17.61 in Q1 2026, from -$0.37 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.37 in Q4 2025 to a low of -$27.45 in Q2 2025.
- A 5-year average of -$19.75 and a median of -$26.12 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 1668.02% — and 2025, when it surged 48.65%.
- Tracing XBIO's EPS (Basic) over 5 years: stood at -$1.12 in 2022, then rose by 26.51% to -$0.82 in 2023, then grew by 13.21% to -$0.71 in 2024, then soared by 48.65% to -$0.37 in 2025, then plunged by 4710.82% to -$17.61 in 2026.
- The last three EPS (Basic) figures came in at -$17.61 (Q1 2026), -$0.37 (Q4 2025), and -$27.39 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Xenetic Biosciences | 7.59 Mn | 1.12 Mn | - | -0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.93 |
| Mar 31, 2026 | -17.61 |
| Dec 31, 2025 | -0.37 |
| Sep 30, 2025 | -27.39 |
| Jun 30, 2025 | -27.45 |
| Mar 31, 2025 | -27.43 |
| Dec 31, 2024 | -0.71 |
| Sep 30, 2024 | -26.66 |
| Jun 30, 2024 | -27.09 |
| Mar 31, 2024 | -26.85 |
| Dec 31, 2023 | -0.82 |
| Sep 30, 2023 | -26.33 |
| Jun 30, 2023 | -26.36 |
| Mar 31, 2023 | -26.12 |
| Dec 31, 2022 | -1.12 |
| Sep 30, 2022 | -23.50 |
| Jun 30, 2022 | -25.09 |
| Mar 31, 2022 | -24.87 |
| Dec 31, 2021 | -1.83 |
| Sep 30, 2021 | -1.33 |